CN101641341A - 酰胺化合物及其作为抗肿瘤剂的用途 - Google Patents

酰胺化合物及其作为抗肿瘤剂的用途 Download PDF

Info

Publication number
CN101641341A
CN101641341A CN200880008093A CN200880008093A CN101641341A CN 101641341 A CN101641341 A CN 101641341A CN 200880008093 A CN200880008093 A CN 200880008093A CN 200880008093 A CN200880008093 A CN 200880008093A CN 101641341 A CN101641341 A CN 101641341A
Authority
CN
China
Prior art keywords
nmr
cdcl
mmol
alkyl
yield
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880008093A
Other languages
English (en)
Chinese (zh)
Inventor
S·哈尼斯安
L·奥扎斯
G·吉安尼尼
C·皮萨诺
L·韦希
W·卡布里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of CN101641341A publication Critical patent/CN101641341A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/01—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having one nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN200880008093A 2007-03-13 2008-03-12 酰胺化合物及其作为抗肿瘤剂的用途 Pending CN101641341A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07104071.1 2007-03-13
EP07104071 2007-03-13

Publications (1)

Publication Number Publication Date
CN101641341A true CN101641341A (zh) 2010-02-03

Family

ID=39535770

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880008093A Pending CN101641341A (zh) 2007-03-13 2008-03-12 酰胺化合物及其作为抗肿瘤剂的用途

Country Status (13)

Country Link
US (1) US20100113504A1 (https=)
EP (1) EP2137169A1 (https=)
JP (1) JP2010520915A (https=)
KR (1) KR20100014974A (https=)
CN (1) CN101641341A (https=)
AU (1) AU2008225833A1 (https=)
BR (1) BRPI0809000A2 (https=)
CA (1) CA2677874A1 (https=)
EA (1) EA200970848A1 (https=)
IL (1) IL200188A0 (https=)
MX (1) MX2009009374A (https=)
WO (1) WO2008110583A1 (https=)
ZA (1) ZA200907077B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109516926A (zh) * 2018-07-27 2019-03-26 四川大学 一种荜茇明碱衍生物的制备与抗肿瘤活性
CN120924186A (zh) * 2025-10-14 2025-11-11 长沙市芯星新能源科技有限公司 负极粘结剂、锂离子电池负极及其制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2230227A1 (en) * 2009-03-20 2010-09-22 Bracco Imaging S.p.A Process for the preparation of triiodinated carboxylic aromatic derivatives
US20120258993A1 (en) * 2009-10-21 2012-10-11 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents
WO2020190827A1 (en) 2019-03-21 2020-09-24 Merck Sharp & Dohme Corp. Inhibitors of histone deacetylase useful for the treatment or prevention of hiv infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ517613A (en) * 1999-09-08 2004-01-30 Sloan Kettering Inst Cancer Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
US20060264415A1 (en) * 2005-04-01 2006-11-23 Methylgene Inc. Inhibitors of histone deacetylase

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109516926A (zh) * 2018-07-27 2019-03-26 四川大学 一种荜茇明碱衍生物的制备与抗肿瘤活性
CN109516926B (zh) * 2018-07-27 2021-09-17 四川大学 一种荜茇明碱衍生物制备及用途
CN120924186A (zh) * 2025-10-14 2025-11-11 长沙市芯星新能源科技有限公司 负极粘结剂、锂离子电池负极及其制备方法
CN120924186B (zh) * 2025-10-14 2025-12-23 长沙市芯星新能源科技有限公司 负极粘结剂、锂离子电池负极及其制备方法

Also Published As

Publication number Publication date
US20100113504A1 (en) 2010-05-06
CA2677874A1 (en) 2008-09-18
BRPI0809000A2 (pt) 2014-11-11
AU2008225833A1 (en) 2008-09-18
IL200188A0 (en) 2010-04-15
EP2137169A1 (en) 2009-12-30
JP2010520915A (ja) 2010-06-17
KR20100014974A (ko) 2010-02-11
WO2008110583A1 (en) 2008-09-18
MX2009009374A (es) 2009-09-21
ZA200907077B (en) 2010-07-28
EA200970848A1 (ru) 2010-02-26

Similar Documents

Publication Publication Date Title
JP7042468B2 (ja) Ｍａｇｌ阻害剤
EP3340988B1 (en) Ion channel inhibitory compounds, pharmaceutical formulations and uses
RU2293727C2 (ru) Амиды антраниловой кислоты с гетероарилсульфонильной боковой цепью и содержащие их фармацевтические композиции
JP6138243B2 (ja) 置換ピペリジノアセトアミドおよびその使用
PH12014501162B1 (en) Aryl dihydropyridinone and piperidinone as mgat2 inhibitors
WO2018110669A1 (en) Activator of trek (twik related k+ channels) channels
CN113429387B (zh) 一种苯并[b]硒吩类STING调控剂、其制备方法及用途
EP3114121A1 (en) Dihydropyridinone mgat2 inhibitors for use in the treatment of metabolic disorders
CN101641341A (zh) 酰胺化合物及其作为抗肿瘤剂的用途
CN113614095A (zh) 作为精氨酸酶抑制剂的烷基硼酸类化合物
CN118290322A (zh) 用于治疗病态状况的芳香型分子
JP7134177B2 (ja) 大環状広域抗生物質
TW200524578A (en) Protease inhibitors
JP7726591B2 (ja) ボロン酸化合物
JP2022550489A (ja) スルホ置換ビアリール化合物又はその塩並びにその調製方法及び使用
JPWO2003064422A1 (ja) イミダゾ［１，２−ａ］ピリジン誘導体
KR20190072530A (ko) 리신 진지파인의 케톤 억제제
CN102066345B (zh) *唑烷衍生物作为nmda拮抗剂
TWI659022B (zh) 作為d-胺基酸氧化酶(daao)抑制劑之新穎經取代苯并咪唑衍生物
TW201821404A (zh) 作為ROR γ調節劑之三環碸
HK1140477A (en) Amide compounds and their use as antitumor agents
CN117242061A (zh) 用于治疗艰难梭菌的二氮杂卓衍生物
IT202100011237A1 (it) Composti inibitori dell’inflammasoma nlrp3 e loro uso
KR20010083109A (ko) 아미노산 유도체 및 이들을 유효 성분으로서 함유하는 약제
CN115093444B (zh) 一种萘磺酰胺磷酸酯类小分子化合物及其应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1140477

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100203

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1140477

Country of ref document: HK